Clinical Trial Detail

NCT ID NCT03843775
Title A Study of Binimetinib and Encorafenib in Advanced BRAF Mutant Cancers
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Memorial Sloan Kettering Cancer Center
Indications

Advanced Solid Tumor

Therapies

Binimetinib + Encorafenib

Age Groups: adult senior

Additional content available in CKB BOOST